BIOTON S.A. (WSE:BIO)
Poland · Delayed Price · Currency is PLN 3.530
+0.085 (2.47%)
Nov 4, 2026, 12:53 PM CET
BIOTON Revenue
BIOTON had revenue of 71.06M PLN in the quarter ending June 30, 2026, a decrease of -11.01%. This brings the company's total for the last twelve months to 257.23M, down -2.98% year-over-year. In the year 2025, BIOTON had annual revenue of 282.52M with 35.98% growth. That makes BIOTON the 25,952nd largest company in the world by revenue and 198th in Poland.
Revenue (ttm)
257.23M
Revenue Growth
-2.98%
P/S Ratio
1.15
Revenue / Employee
708.61K
Employees
364
Market Cap
303.10M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full BIOTON breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 282.52M | 74.76M | 35.98% |
| Dec 31, 2024 | 207.76M | 26.13M | 14.38% |
| Dec 31, 2023 | 181.64M | -51.52M | -22.10% |
| Dec 31, 2022 | 233.16M | 70.13M | 43.01% |
| Dec 31, 2021 | 163.03M | -58.75M | -26.49% |
| Dec 31, 2020 | 221.79M | 19.76M | 9.78% |
| Dec 31, 2019 | 202.03M | -39.13M | -16.23% |
| Dec 31, 2018 | 241.17M | -120.48M | -33.31% |
| Dec 31, 2017 | 361.65M | 13.86M | 3.98% |
| Dec 31, 2016 | 347.79M | -56.61M | -14.00% |
| Dec 31, 2015 | 404.41M | 27.11M | 7.18% |
| Dec 31, 2014 | 377.30M | 36.95M | 10.85% |
| Dec 31, 2013 | 340.36M | -65.95M | -16.23% |
| Dec 31, 2012 | 406.30M | 117.32M | 40.60% |
| Dec 31, 2011 | 288.98M | -89.11M | -23.57% |
| Dec 31, 2010 | 378.10M | 161.25M | 74.36% |
| Dec 31, 2009 | 216.85M | -76.67M | -26.12% |
| Dec 31, 2008 | 293.52M | 22.58M | 8.33% |
| Dec 31, 2007 | 270.94M | 55.46M | 25.74% |
| Dec 31, 2006 | 215.48M | 63.89M | 42.15% |
| Dec 31, 2005 | 151.59M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ryvu Therapeutics | 83.94M |
| Synthaverse | 48.76M |
| Mabion | 17.61M |
| Read-Gene | 16.66M |
| Molecure | 6.52M |
| Urteste | 2.77M |
| NanoGroup | 2.37M |
| Captor Therapeutics Spolka Akcyjna | 2.01M |